Showing results (351-360 of 471) with videos related to
Sort By:
Pageof 48
Medicine and Science in Sports and Exercise|May 8, 2008
Relationships among fitness, body composition, and physical activityTimothy G Lohman, Kimberly Ring, Karin Pfeiffer, et al.Journal of Human Stress|January 1, 1985
Measurement assessment of the type A coronary prone behavior pattern and hyperactivity/problem behaviors in children: are they related? The Bogalusa Heart StudyS M Hunter, F C Parker, G D Williamson, et al.The Journal of School Health|January 1, 1986
Factors associated with adolescent participation in a cardiovascular risk factor assessment programF C Parker, J B Croft, J D Supik, et al.Behavioural Brain Research|June 16, 2009
Wistar-Kyoto rats as an animal model of anxiety vulnerability: support for a hypervigilance hypothesisJ D McAuley, A L Stewart, E S Webber, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 14, 1998
Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylateJ H Lillibridge, B H Liang, B M Kerr, et al.American Journal of Clinical Pathology|August 1, 1986
Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor bloodJ E Barrett, G Dawson, J Heller, et al.European Journal of Pharmacology|June 16, 2001
Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the ratS L Underwood, S McMillan, R Reeves, et al.Metabolism: Clinical and Experimental|May 1, 1986
Influence of serum lipoproteins and carbohydrate metabolism on erythrocyte membrane composition in children: Bogalusa Heart StudyS R Srinivasan, C Amos, R Albares, et al.British Journal of Pharmacology|May 1, 1995
Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipramJ E Souness, C Maslen, S Webber, et al.Pediatrics|November 1, 1987
Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Dietary intakesT A Nicklas, R P Farris, C Major, et al.Pageof 48